Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Woolly mammoth secret points toward new artificial blood for humans

By Drug Discovery Trends Editor | September 15, 2011

The blood from woolly
mammoths—those extinct elephant-like creatures that roamed the Earth in
pre-historic times—is helping scientists develop new blood products for modern
medical procedures that involve reducing patients’ body temperature. The report
appears in Biochemistry.

Chien Ho and colleagues note that
woolly mammoth ancestors initially evolved in warm climates, where African and
Asian elephants live now, but migrated to the cold regions of Eurasia
1.2 million—2.0 million years ago in the Pleistocene ice age. They adapted to
their new environment by growing thick, “woolly” fur and smaller ears, which
helped conserve heat, and possibly by changing their DNA. In previous research,
Ho and colleagues discovered that a blood protein (hemoglobin) that carries
oxygen from the lungs to the rest of the body in the woolly mammoth has
mutations in its DNA that make it different from that of its cousin, the Asian
elephant. The scientists turned to the mutations that helped woolly mammoths survive
freezing temperatures, and carefully analyzed hemoglobin from the ancient
animal.

They didn’t have a woolly mammoth
blood sample, so they made the hemoglobin protein in the laboratory by using
fragmented DNA sequences from three mammoths that died in Siberia
between 25,000 and 43,000 years ago. Compared to hemoglobin from Asian
elephants and humans, the woolly mammoth protein was much less sensitive to
temperature changes, which means it can still easily unload oxygen to tissues
that need it in the cold, whereas the other hemoglobins can’t. This is likely
due to at least two of the mutations in the woolly mammoth hemoglobin gene.
These insights could lead to the design of new artificial blood products for
use in hypothermia induced during heart and brain surgeries.

SOURCE

Article Abstract


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE